Table 2.

Multivariable RR of impairment (and 95% CI) in neurocognition, emotional distress, and quality of life associated with demographic and clinical factors

CharacteristicNeurocognitiveEmotional distress
Task efficiency (n = 1388) RR (95% CI)Emotional regulation (n = 1415) RR (95% CI)Organization (n = 1414) RR (95% CI)Memory (n = 1413) RR (95% CI)Anxiety (n = 1466) RR (95% CI)Depression (n = 1467) RR (95% CI)
Female sex (vs male) 1.15 (0.84-1.57) 1.42 (1.11-1.82) 0.89 (0.66-1.19) 1.98 (1.34-2.94) 0.68 (0.46-1.00) 0.87 (0.62-1.22) 
Other race (vs white) 1.67 (1.07-2.62) 1.40 (0.94-2.10) 1.19 (0.73-1.94) 1.44 (0.81-2.55) 0.95 (0.46-1.95) 1.40 (0.82-2.39) 
Former smoker (vs never) 1.45 (1.01-2.08) 1.33 (1.00-1.77) 1.01 (0.70-1.45) 1.76 (1.16-2.67) 1.83 (1.17-2.86) 1.49 (0.98-2.26) 
Current smoker (vs never) 1.56 (1.02-2.39) 1.84 (1.35-2.49) 1.05 (0.67-1.64) 1.46 (0.87-2.47) 2.43 (1.51-3.93) 2.73 (1.85-4.04) 
Meet CDC exercise guidelines (yes vs no) 0.70 (0.52-0.95) 0.95 (0.75-1.19) 0.60 (0.45-0.80) 0.88 (0.61-1.27) 0.87 (0.59-1.29) 0.66 (0.48-0.92) 
Overweight BMI (vs normal/underweight) 1.33 (0.94-1.90) 1.05 (0.79-1.40) 1.17 (0.84-1.64) 1.15 (0.74-1.78) 1.33 (0.89-2.01) 1.26 (0.87-1.83) 
Obese BMI (vs normal/underweight) 1.39 (0.95-2.03) 1.64 (1.26-2.13) 1.24 (0.87-1.78) 1.61 (1.04-2.47) 0.92 (0.55-1.53) 1.18 (0.77-1.79) 
Relapse/subsequent malignancy (yes vs no) 1.65 (1.18-2.31) 1.17 (0.88-1.54) 1.42 (1.01-2.01) 1.16 (0.77-1.75) 1.28 (0.81-2.01) 1.24 (0.83-1.85) 
Anthracycline (yes vs no) 1.10 (0.71-1.71) 0.56 (0.38-0.82) 0.70 (0.44-1.10) 1.25 (0.69-2.24) 0.62 (0.33-1.16) 0.73 (0.42-1.26) 
Bleomycin (yes vs no) 0.79 (0.52-1.21) 0.98 (0.67-1.42) 1.31 (0.87-1.99) 1.05 (0.61-1.81) 1.34 (0.74-2.41) 1.27 (0.75-2.16) 
Corticosteroids (yes vs no) 1.01 (0.67-1.53) 0.98 (0.71-1.35) 1.57 (1.02-2.42) 0.87 (0.51-1.47) 1.99 (1.13-3.50) 1.49 (0.91-2.44) 
Chest radiation (yes vs no) 1.05 (0.71-1.54) 1.11 (0.81-1.51) 0.98 (0.68-1.39) 1.13 (0.73-1.75) 0.94 (0.60-1.47) 0.86 (0.58-1.28) 
Alkylating agents (yes vs no) 1.31 (0.86-2.01) 1.34 (0.96-1.87) 0.61 (0.40-0.92) 0.97 (0.57-1.64) 0.94 (0.54-1.64) 1.05 (0.63-1.73) 
CharacteristicNeurocognitiveEmotional distress
Task efficiency (n = 1388) RR (95% CI)Emotional regulation (n = 1415) RR (95% CI)Organization (n = 1414) RR (95% CI)Memory (n = 1413) RR (95% CI)Anxiety (n = 1466) RR (95% CI)Depression (n = 1467) RR (95% CI)
Female sex (vs male) 1.15 (0.84-1.57) 1.42 (1.11-1.82) 0.89 (0.66-1.19) 1.98 (1.34-2.94) 0.68 (0.46-1.00) 0.87 (0.62-1.22) 
Other race (vs white) 1.67 (1.07-2.62) 1.40 (0.94-2.10) 1.19 (0.73-1.94) 1.44 (0.81-2.55) 0.95 (0.46-1.95) 1.40 (0.82-2.39) 
Former smoker (vs never) 1.45 (1.01-2.08) 1.33 (1.00-1.77) 1.01 (0.70-1.45) 1.76 (1.16-2.67) 1.83 (1.17-2.86) 1.49 (0.98-2.26) 
Current smoker (vs never) 1.56 (1.02-2.39) 1.84 (1.35-2.49) 1.05 (0.67-1.64) 1.46 (0.87-2.47) 2.43 (1.51-3.93) 2.73 (1.85-4.04) 
Meet CDC exercise guidelines (yes vs no) 0.70 (0.52-0.95) 0.95 (0.75-1.19) 0.60 (0.45-0.80) 0.88 (0.61-1.27) 0.87 (0.59-1.29) 0.66 (0.48-0.92) 
Overweight BMI (vs normal/underweight) 1.33 (0.94-1.90) 1.05 (0.79-1.40) 1.17 (0.84-1.64) 1.15 (0.74-1.78) 1.33 (0.89-2.01) 1.26 (0.87-1.83) 
Obese BMI (vs normal/underweight) 1.39 (0.95-2.03) 1.64 (1.26-2.13) 1.24 (0.87-1.78) 1.61 (1.04-2.47) 0.92 (0.55-1.53) 1.18 (0.77-1.79) 
Relapse/subsequent malignancy (yes vs no) 1.65 (1.18-2.31) 1.17 (0.88-1.54) 1.42 (1.01-2.01) 1.16 (0.77-1.75) 1.28 (0.81-2.01) 1.24 (0.83-1.85) 
Anthracycline (yes vs no) 1.10 (0.71-1.71) 0.56 (0.38-0.82) 0.70 (0.44-1.10) 1.25 (0.69-2.24) 0.62 (0.33-1.16) 0.73 (0.42-1.26) 
Bleomycin (yes vs no) 0.79 (0.52-1.21) 0.98 (0.67-1.42) 1.31 (0.87-1.99) 1.05 (0.61-1.81) 1.34 (0.74-2.41) 1.27 (0.75-2.16) 
Corticosteroids (yes vs no) 1.01 (0.67-1.53) 0.98 (0.71-1.35) 1.57 (1.02-2.42) 0.87 (0.51-1.47) 1.99 (1.13-3.50) 1.49 (0.91-2.44) 
Chest radiation (yes vs no) 1.05 (0.71-1.54) 1.11 (0.81-1.51) 0.98 (0.68-1.39) 1.13 (0.73-1.75) 0.94 (0.60-1.47) 0.86 (0.58-1.28) 
Alkylating agents (yes vs no) 1.31 (0.86-2.01) 1.34 (0.96-1.87) 0.61 (0.40-0.92) 0.97 (0.57-1.64) 0.94 (0.54-1.64) 1.05 (0.63-1.73) 
CharacteristicQuality of life
General health (n = 1423) RR (95% CI)Physical function (n = 1548) RR (95% CI)Physical role limitation (n = 1545) RR (95% CI)Pain (n = 1549) RR (95% CI)Emotional role limitation (n = 1539) RR (95% CI)Vitality (n = 1427) RR (95% CI)Social functioning (n = 1551) RR (95% CI)Mental health (n = 1426) RR (95% CI)
Female sex (vs male) 1.22 (1.03-1.44) 1.58 (1.16-2.13) 1.12 (0.88-1.43) 1.31 (1.04-1.66) 1.38 (1.08-1.77) 1.56 (1.27-1.93) 1.57 (1.20-2.05) 1.37 (1.06-1.75) 
Other race (vs white) 0.90 (0.65-1.24) 1.28 (0.77-2.11) 1.45 (0.99-2.12) 0.86 (0.53-1.39) 1.62 (1.11-2.36) 1.12 (0.79-1.58) 1.43 (0.96-2.12) 1.40 (0.95-2.07) 
Former smoker (vs never) 1.08 (0.88-1.32) 1.31 (0.93-1.83) 1.18 (0.90-1.55) 1.22 (0.93-1.61) 1.64 (1.24-2.17) 1.23 (0.98-1.55) 1.31 (0.96-1.78) 1.54 (1.15-2.06) 
Current smoker (vs never) 1.39 (1.12-1.73) 1.49 (1.00-2.20) 1.47 (1.07-2.03) 2.01 (1.52-2.65) 1.93 (1.42-2.63) 1.43 (1.10-1.86) 1.78 (1.28-2.47) 2.40 (1.80-3.18) 
Meet CDC exercise guidelines (yes vs no) 0.64 (0.55-0.75) 0.33 (0.24-0.45) 0.58 (0.46-0.73) 0.71 (0.57-0.89) 0.82 (0.65-1.04) 0.60 (0.49-0.72) 0.64 (0.50-0.82) 0.78 (0.61-0.99) 
Overweight BMI (vs normal/underweight) 1.22 (1.00-1.48) 0.93 (0.65-1.33) 0.92 (0.70-1.20) 1.35 (1.04-1.76) 1.28 (0.97-1.68) 1.11 (0.88-1.40) 1.27 (0.95-1.70) 1.53 (1.16-2.01) 
Obese BMI (vs normal/underweight) 1.65 (1.37-2.00) 1.58 (1.13-2.20) 1.27 (0.96-1.67) 1.72 (1.31-2.26) 1.34 (1.00-1.80) 1.43 (1.15-1.79) 1.39 (1.02-1.90) 1.52 (1.12-2.05) 
Relapse/subsequent malignancy (yes vs no) 1.24 (1.03-1.49) 1.43 (1.04-1.96) 1.34 (1.03-1.75) 1.26 (0.97-1.64) 1.04 (0.78-1.39) 1.25 (1.00-1.55) 0.99 (0.72-1.36) 0.78 (0.57-1.08) 
Anthracycline (yes vs no) 0.86 (0.67-1.11) 0.76 (0.48-1.19) 0.69 (0.46-1.03) 0.53 (0.35-0.78) 0.69 (0.46-1.05) 0.71 (0.52-0.97) 0.86 (0.57-1.30) 0.71 (0.48-1.06) 
Bleomycin (yes vs no) 0.99 (0.78-1.25) 0.95 (0.60-1.50) 0.98 (0.66-1.46) 1.10 (0.75-1.61) 0.97 (0.65-1.43) 1.25 (0.93-1.67) 1.28 (0.86-1.90) 1.30 (0.90-1.86) 
Corticosteroids (yes vs no) 0.83 (0.67-1.03) 1.04 (0.68-1.59) 1.00 (0.72-1.39) 0.87 (0.63-1.19) 0.96 (0.68-1.34) 0.96 (0.75-1.24) 1.01 (0.73-1.42) 1.23 (0.88-1.71) 
Chest radiation (yes vs no) 1.14 (0.91-1.41) 1.12 (0.75-1.67) 1.06 (0.78-1.46) 0.81 (0.61-1.08) 0.87 (0.65-1.16) 1.05 (0.82-1.35) 0.91 (0.66-1.25) 1.11 (0.82-1.50) 
Alkylating agent (yes vs no) 1.30 (1.05-1.61) 1.27 (0.83-1.94) 1.16 (0.83-1.62) 1.34 (0.97-1.86) 1.01 (0.73-1.41) 1.06 (0.83-1.37) 1.09 (0.78-1.52) 0.92 (0.67-1.27) 
CharacteristicQuality of life
General health (n = 1423) RR (95% CI)Physical function (n = 1548) RR (95% CI)Physical role limitation (n = 1545) RR (95% CI)Pain (n = 1549) RR (95% CI)Emotional role limitation (n = 1539) RR (95% CI)Vitality (n = 1427) RR (95% CI)Social functioning (n = 1551) RR (95% CI)Mental health (n = 1426) RR (95% CI)
Female sex (vs male) 1.22 (1.03-1.44) 1.58 (1.16-2.13) 1.12 (0.88-1.43) 1.31 (1.04-1.66) 1.38 (1.08-1.77) 1.56 (1.27-1.93) 1.57 (1.20-2.05) 1.37 (1.06-1.75) 
Other race (vs white) 0.90 (0.65-1.24) 1.28 (0.77-2.11) 1.45 (0.99-2.12) 0.86 (0.53-1.39) 1.62 (1.11-2.36) 1.12 (0.79-1.58) 1.43 (0.96-2.12) 1.40 (0.95-2.07) 
Former smoker (vs never) 1.08 (0.88-1.32) 1.31 (0.93-1.83) 1.18 (0.90-1.55) 1.22 (0.93-1.61) 1.64 (1.24-2.17) 1.23 (0.98-1.55) 1.31 (0.96-1.78) 1.54 (1.15-2.06) 
Current smoker (vs never) 1.39 (1.12-1.73) 1.49 (1.00-2.20) 1.47 (1.07-2.03) 2.01 (1.52-2.65) 1.93 (1.42-2.63) 1.43 (1.10-1.86) 1.78 (1.28-2.47) 2.40 (1.80-3.18) 
Meet CDC exercise guidelines (yes vs no) 0.64 (0.55-0.75) 0.33 (0.24-0.45) 0.58 (0.46-0.73) 0.71 (0.57-0.89) 0.82 (0.65-1.04) 0.60 (0.49-0.72) 0.64 (0.50-0.82) 0.78 (0.61-0.99) 
Overweight BMI (vs normal/underweight) 1.22 (1.00-1.48) 0.93 (0.65-1.33) 0.92 (0.70-1.20) 1.35 (1.04-1.76) 1.28 (0.97-1.68) 1.11 (0.88-1.40) 1.27 (0.95-1.70) 1.53 (1.16-2.01) 
Obese BMI (vs normal/underweight) 1.65 (1.37-2.00) 1.58 (1.13-2.20) 1.27 (0.96-1.67) 1.72 (1.31-2.26) 1.34 (1.00-1.80) 1.43 (1.15-1.79) 1.39 (1.02-1.90) 1.52 (1.12-2.05) 
Relapse/subsequent malignancy (yes vs no) 1.24 (1.03-1.49) 1.43 (1.04-1.96) 1.34 (1.03-1.75) 1.26 (0.97-1.64) 1.04 (0.78-1.39) 1.25 (1.00-1.55) 0.99 (0.72-1.36) 0.78 (0.57-1.08) 
Anthracycline (yes vs no) 0.86 (0.67-1.11) 0.76 (0.48-1.19) 0.69 (0.46-1.03) 0.53 (0.35-0.78) 0.69 (0.46-1.05) 0.71 (0.52-0.97) 0.86 (0.57-1.30) 0.71 (0.48-1.06) 
Bleomycin (yes vs no) 0.99 (0.78-1.25) 0.95 (0.60-1.50) 0.98 (0.66-1.46) 1.10 (0.75-1.61) 0.97 (0.65-1.43) 1.25 (0.93-1.67) 1.28 (0.86-1.90) 1.30 (0.90-1.86) 
Corticosteroids (yes vs no) 0.83 (0.67-1.03) 1.04 (0.68-1.59) 1.00 (0.72-1.39) 0.87 (0.63-1.19) 0.96 (0.68-1.34) 0.96 (0.75-1.24) 1.01 (0.73-1.42) 1.23 (0.88-1.71) 
Chest radiation (yes vs no) 1.14 (0.91-1.41) 1.12 (0.75-1.67) 1.06 (0.78-1.46) 0.81 (0.61-1.08) 0.87 (0.65-1.16) 1.05 (0.82-1.35) 0.91 (0.66-1.25) 1.11 (0.82-1.50) 
Alkylating agent (yes vs no) 1.30 (1.05-1.61) 1.27 (0.83-1.94) 1.16 (0.83-1.62) 1.34 (0.97-1.86) 1.01 (0.73-1.41) 1.06 (0.83-1.37) 1.09 (0.78-1.52) 0.92 (0.67-1.27) 

Bold indicates statistical significance (P < .05). Models for each risk of impairment are mutually adjusted for the variables above in addition to age at diagnosis and time since diagnosis.

BMI, body mass index.

Close Modal

or Create an Account

Close Modal
Close Modal